Ellen Connolly
About Ellen Connolly
Ellen Connolly serves as the Vice President of Regulatory Affairs at ANI Pharmaceuticals, Inc., a position she has held since 2016. She has extensive experience in regulatory affairs, having previously worked at Sandoz and ANI Pharmaceuticals in various roles.
Current Role at ANI Pharmaceuticals
Ellen Connolly serves as the Vice President of Regulatory Affairs at ANI Pharmaceuticals, Inc. She has held this position since 2016. In her role, she oversees regulatory strategies and compliance, ensuring that the company meets all necessary regulations for pharmaceutical products. Her leadership contributes to the development and submission of regulatory filings, facilitating the approval process for new medications.
Previous Experience at ANI Pharmaceuticals
Before her current role, Ellen Connolly worked at ANI Pharmaceuticals, Inc. as the Director of Regulatory Affairs from 2012 to 2016. During her tenure, she was responsible for managing regulatory submissions and interactions with health authorities. Her experience in this position laid the groundwork for her advancement to Vice President.
Experience at Sandoz
Ellen Connolly has significant experience from her time at Sandoz. She worked as a Supervisor in Analytical R&D from 2006 to 2008, where she led projects in the Raleigh-Durham, North Carolina area. Following this role, she served as a Senior Associate in Regulatory Affairs from 2008 to 2012, focusing on regulatory compliance and submissions.
Educational Background
Ellen Connolly studied at New York University, where she earned a Bachelor of Arts degree in Chemistry from 1997 to 2000. Prior to that, she attended Boston University for one year in 1996 to 1997. Her educational background in chemistry provides a strong foundation for her work in regulatory affairs within the pharmaceutical industry.